1. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?
   Javier Martinez-Useros et al, 2016, BioMed Research International CrossRef
2. LncRNAs in Stem Cells
   Shanshan Hu et al, 2016, Stem Cells International CrossRef
3. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
   Mohammad Aslam Khan et al, 2017, IJMS CrossRef
4. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.
   Richard Heery et al, 2017, Cancers (Basel) CrossRef
5. Cancer–Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer
   Aimy Sebastian et al, 2015, Microarrays CrossRef
6. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer
   Er-Jun Pang et al, 2015, Tumor Biol. CrossRef
7. Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer
   Hai Hu et al, 2017, Sci Rep CrossRef
8. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer
   Shibin Qu et al, 2016, Tumor Biol. CrossRef
9. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma
   Pingping Liu et al, 2017, Sci Rep CrossRef
10. Novel Implications of Exosomes and lncRNAs in the Diagnosis and Treatment of Pancreatic Cancer
    Jin Wang et al, 2017 CrossRef
11. Synergisic effect of APRIL knockdown and Jiedu Xiaozheng Yin, a Chinese medicinal recipe, on the inhibition of hepatocellular carcinoma cell proliferation
    Zhizhen Liu et al, 2017 CrossRef
12. Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review)
    Min Fu et al, 2016 CrossRef
13. Anticancer activity in vitro and biological safety evaluation in vivo of Sika deer antler protein
    Huihai Yang et al, 2017, J Food Biochem CrossRef
14. Noncoding RNAs and pancreatic cancer.
    Juan-Fei Peng et al, 2016, World J Gastroenterol CrossRef
15. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma
    Dou-Dou Li, 2015, WJG CrossRef
16. "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma
    Gary A. Clawson et al, 2017, PLoS ONE CrossRef
17. The involvement of lncRNAs in the development and progression of pancreatic cancer
    Li Duguang et al, 2017, Cancer Biology & Therapy CrossRef
18. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells
    Jia-Qiang Zhang et al, 2018, J. Cell. Biochem. CrossRef
19. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
    Haidy E Zidan et al, 2018, Cancer Genet CrossRef
20. The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma
    Li-Juan Li et al, 2017, Biomedicine & Pharmacotherapy CrossRef
21. Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis
    Ke-Ke Sun et al, 2017, J. Cell. Biochem. CrossRef
22. Elevated RNA expression of long non-coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma
    YULING YAN et al, 2016 CrossRef
23. Ulinastatin protects against lipopolysaccharide-induced cardiac microvascular endothelial cell dysfunction via downregulation of lncRNA MALAT1 and EZH2 in sepsis
    Zhaoxia Yu et al, 2017 CrossRef
24. LncRNAs and cancer
    Rui Zhang et al, 2016 CrossRef
25. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma
    Hao Chen et al, 2018, Thorac Cancer CrossRef
26. Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells.
    Feng Jiao et al, 2015, Int J Mol Sci CrossRef
27. Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer
    Yating Cheng et al, 2018, PLoS ONE CrossRef
28. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy
    Jun Ma et al, 2018, CBM CrossRef
29. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression
    Feng Zhu et al, 2018, J. Cell. Biochem. CrossRef
30. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling
    Yongping Zhou et al, 2018, J Cell Physiol CrossRef
31. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
    Jens C. Hahne et al, 2018, Front. Oncol. CrossRef
32. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer
    Jiasheng Wu et al, 2018, Anti-Cancer Drugs CrossRef
33. Long Noncoding RNAs Regulate Cell Growth, Proliferation, and Apoptosis
    Jingqiu Li et al, 2016, DNA and Cell Biology CrossRef
34. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis
    Juan Li et al, 2018, Cancer Cell Int CrossRef
35. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer
    Lumir Kunovsky et al, 2018, Canadian Journal of Gastroenterology and Hepatology CrossRef
36. Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing
    Duguang Li et al, 2018, DNA and Cell Biology CrossRef
37. Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments
    Jinyuan Xu et al, 2018, EBioMedicine CrossRef
38. The emerging role of lncRNAs in the regulation of cancer stem cells
    Rosario Castro-Oropeza et al, 2018, Cell Oncol. CrossRef
39. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis
    Meng Zhuo et al, 2018, BMC Cancer CrossRef
40. LINC00052 functions as a tumor suppressor through negatively modulating miR-330-3p in pancreatic cancer
    Xingcheng Xiong et al, 2019, J Cell Physiol CrossRef
41. Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma
    Alaa Habib et al, 2019, Mol Biol Rep CrossRef
42. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer
    Ingrid Garajová et al, 2019, CPD CrossRef
43. Chronic inflammation evoked by pathogenic stimulus during carcinogenesis
    Björn L.D.M. Brücher et al, 2019, 4open CrossRef
44. Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer
    Shafquat Azim et al, 2016, Sci Rep CrossRef
45. Inhibition of G9a promoted 5-fluorouracil (5-FU) induced gastric cancer cell apoptosis via ROS/JNK signaling pathway in vitro and in vivo
    Haizhou Lou et al, 2019, RSC Adv. CrossRef
46. The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance
    Marjan E. Askarian-Amiri et al, 2016 CrossRef
47. Long non-coding RNA: A new paradigm for lung cancer
    Akanksha Khandelwal et al, 2015, Mol. Carcinog. CrossRef
48. Prognostic value of long non-coding RNA MALAT1 in cancer patients
    Yihua Wu et al, 2016, Tumor Biol. CrossRef
49. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies
    Yuan Xue et al, 2016, Tumor Biol. CrossRef
50. ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression
    Peng Li et al, 2019, Autophagy CrossRef
51. PRINS, a primate-specific long non-coding RNA, plays a role in the keratinocyte stress response and psoriasis pathogenesis
    Márta Széll et al, 2016, Pflugers Arch - Eur J Physiol CrossRef
52. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
    V. Taucher et al, 2016, Cell Oncol. CrossRef
53. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis.
    Chunyang Jiang et al, 2016, Mol Cancer CrossRef
54. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis
    Ping Shuai et al, 2016, SpringerPlus CrossRef
55. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
    Maria C Previdi et al, 2017, Future Oncol CrossRef
56. MiR-216a decreases MALAT1 expression, induces G2/M arrest and apoptosis in pancreatic cancer cells
    Yajing Zhang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
57. Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma
    Max M. Träger et al, 2017, Int. J. Cancer CrossRef
58. LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma
    Da Gao et al, 2017, J. Cell. Biochem. CrossRef
59. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche
    Hajar Rajayi et al, 2019, International Reviews of Immunology CrossRef
60. Expression Profiles of lncRNAs and circRNAs in Keloid
    Jie Wang et al, 2019, Plastic and Reconstructive Surgery - Global Open CrossRef
61. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis
    Soudeh Ghafouri-Fard et al, 2019, Experimental and Molecular Pathology CrossRef
62. Targeting the epigenome as a therapeutic strategy for pancreatic tumors
    Sathish Kumar Mungamuri, 2019 CrossRef
63. Cancer Simulation from Stage Minus One by Quantum microRNA Language: Lung, Colorectal and Pancreatic Cancers
    , 2019, Med One CrossRef
64. LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis
    Jian Yang et al, 2020, In Vitro Cell.Dev.Biol.-Animal CrossRef
65. A comprehensive review of the role of long non-coding RNAs in organs with an endocrine function
    Soudeh Ghafouri-Fard et al, 2020, Biomedicine & Pharmacotherapy CrossRef
66. Identification and analysis of consensus RNA motifs binding to the genome regulator CTCF
    Shuzhen Kuang et al, 2020 CrossRef
67. lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients
    Cui-Juan Wang et al, 2017, Oncotarget CrossRef
68. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
    Ting Han et al, 2016, Oncotarget CrossRef
69. Development of novel long noncoding RNA MALAT1 near-infrared optical probes for in vivo tumour imaging
    Meng-Jie Dong et al, 2017, Oncotarget CrossRef
70. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2
    Wei Wang et al, 2016, Oncotarget CrossRef
71. Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer
    Zijun Xie et al, 2016, Oncotarget CrossRef
72. LncRNAs in pancreatic cancer
    Xiaoyi Huang et al, 2016, Oncotarget CrossRef
73. Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer.
    Jue Liu et al, 2016, Oncotarget CrossRef
74. Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients
    Jiong Hu et al, 2016, Oncotarget CrossRef
75. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer
    Nai-si Huang et al, 2016, Oncotarget CrossRef
76. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2
    Wenwu Du et al, 2020, Biochem. Cell Biol. CrossRef
77. Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma.
    Juan Sun et al, 0 CrossRef
78. MicroRNA‑539 inhibits cell proliferation, colony formation and invasion in pancreatic ductal adenocarcinoma by directly targeting IGF‑1R.
    Yongquan Lin et al, 0 CrossRef
79. Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network.
    Guomei Ye et al, 2019, Exp Ther Med CrossRef
80. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing
    Li Zhang et al, 2018, Int J Oncol CrossRef
81. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
    Xing Liang et al, 0 CrossRef
82. Emerging role of long non‑coding RNA MALAT1 in predicting clinical outcomes of patients with digestive system malignancies: A meta‑analysis
    Chao Wang et al, 2018, Oncol Lett CrossRef
83. MALAT1: A long non‑coding RNA highly associated with human cancers (Review)
    Miaomiao Zhao et al, 2018, Oncol Lett CrossRef
84. Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer
    Markus Glaß et al, 2020, Cancers CrossRef
85. Regulation of a long noncoding RNA MALAT1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues
    Ji-eun Lee et al, 2020, Biochemical and Biophysical Research Communications CrossRef
86. Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor Angiogenesis
    Julia Teppan et al, 2020, ncRNA CrossRef
87. Noncoding RNAs in drug-resistant pancreatic cancer: A review
    Zhengjun Lin et al, 2020, Biomedicine & Pharmacotherapy CrossRef
88. Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.
    Le Li et al, 2016, Mol Cancer Ther CrossRef
89. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
    Rana Shafabakhsh et al, 2021, Cancer Gene Ther CrossRef
90. The journey of noncoding RNA from bench to clinic
    Ravindresh Chhabra, 2021 CrossRef
91. Human Mesenchymal Stem Cell-Derived Exosomal microRNA-143 Promotes Apoptosis and Suppresses Cell Growth in Pancreatic Cancer via Target Gene Regulation
    Bingyi Wang et al, 2021, Front. Genet. CrossRef
92. Serum Long Non-Coding RNAs PVT1, HOTAIR, and NEAT1 as Potential Biomarkers in Egyptian Women with Breast Cancer.
    Amal Ahmed Abd El-Fattah et al, 2021, Biomolecules CrossRef
93. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy
    Maria Mortoglou et al, 2021, Translational Oncology CrossRef
94. Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas
    Suyan Tian et al, 2021, Aging CrossRef
95. Long non-coding RNAs in cancer stem cells
    Melanie Schwerdtfeger et al, 2021, Translational Oncology CrossRef
96. Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer
    Ammad Ahmad Farooqi et al, 2021, Front. Oncol. CrossRef
97. MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis.
    Tianzhu Yu et al, 2021, RNA Biol CrossRef
98. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
    Jorge Melendez-Zajgla et al, 2021, IJMS CrossRef
99. Bifacial PNAs Destabilize MALAT1 by 3′ A-Tail Displacement from the U-Rich Internal Loop
    Shiqin Miao et al, 2021, ACS Chem. Biol. CrossRef
100. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs
     Yiwei Li et al, 2021, Cancers CrossRef
101. PFOI stimulates the motility of T24 bladder cancer cells: Possible involvement and activation of lncRNA malat1
     Yuying Yang et al, 2021, Chemosphere CrossRef
102. A Perspective on the Role of Autophagy in Cancer
     Aileen R. Ariosa et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
103. Epigenetics in precision medicine of pancreatic cancer
     Hong Sun Kim et al, 2022 CrossRef
104. Discovery of Relationships Between Long Non-Coding RNAs and Genes in Human Diseases Based on Tensor Completion
     Chen Peng et al, 2018, IEEE Access CrossRef
105. Long Noncoding RNA Acting as Therapeutic Target for Oxidative Stress-Induced Pancreatic Cancer
     Nilabja Sikdar et al, 2022 CrossRef
106. Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance
     Jiajia Li et al, 2022, Cancers CrossRef
107. Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer
     Xiaoying Yang et al, 2022, Front. Oncol. CrossRef
108. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer
     Jichuan Xu et al, 2022, Cell Death Discov. CrossRef
109. Targeting epigenetic alterations in cancer stem cells
     Verona F. et al, 2022, Front. Mol. Med CrossRef
110. Biogenesis, classification, and role of LncRNAs in tumor angiogenesis: A focus on tumor and its neighbouring cells, and interaction with miRNAs
     Selvaraj Vimalraj et al, 2022, Process Biochemistry CrossRef
111. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
     Zhengwei Song et al, 2022, Front. Oncol. CrossRef
112. Long Noncoding RNA Acting as Therapeutic Target for Oxidative Stress-Induced Pancreatic Cancer
     Nilabja Sikdar et al, 2022 CrossRef
113. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance
     Xiao-Yin Jiang et al, 2022, Hepatobiliary & Pancreatic Diseases International CrossRef
114. Autophagy-Related ncRNAs in Pancreatic Cancer
     Simone Donati et al, 2022, Pharmaceuticals CrossRef
115. Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer
     Rui Xin et al, 2023, Pulmonary Pharmacology & Therapeutics CrossRef
116. Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer
     Ying Xu et al, 2023, IJMS CrossRef
117. The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer
     Ahmed Hjazi et al, 2023, Pathology - Research and Practice CrossRef
118. The MALAT1-breast cancer interplay: insights and implications
     Muhammad Tufail, 2023, Expert Review of Molecular Diagnostics CrossRef
119. Long non-coding RNAs and pancreatic cancer: A multifaceted view
     null Bin Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
120. MALAT-1 Is a Key Regulator of Epithelial–Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis
     Mohamed Ali Hussein et al, 2024, Cancers CrossRef
121. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance
     Dexin Xu et al, 2024, Non-coding RNA Research CrossRef
122. Involvement of epigenetic modifications in cancer stem cells and chemoresistance
     Prajakta Oak et al, 2024 CrossRef
123. Competing Endogenous RNAs Regulatory Crosstalk Networks: The Messages from the RNA World to Signaling Pathways Directing Cancer Stem Cell Development
     Hamid Aria et al, 2024, Heliyon CrossRef
124. Long non-coding RNAs in pancreatic cancer
     Yuan Chen et al, 2024, Clinica Chimica Acta CrossRef